Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Blueprint Medicines Corp.

NAS: BPMC

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Blueprint Medicines Corp.

After Hours

BPMC
/zigman2/quotes/209215354/composite

$

69.99

Change

+0.87 +1.26%

Volume

Volume 123,419

Nov 27, 2023, 6:56 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209215354/composite

Previous close

$ 68.45

$ 69.12

Change

+0.67 +0.98%

Day low

Day high

$67.04

$69.17

Open
Open: 68.52

52 week low

52 week high

$37.82

$69.17

Open

Market cap

$4.16B

Average volume

693,813

P/E ratio

N/A

Rev. per Employee

$337,292

EPS

-9.20

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bpmc

MarketWatch News on BPMC

  1. Blueprint Medicines upgraded to outperform from perform at Oppenheimer

    7:32 a.m. Oct. 27, 2023

    - Tomi Kilgore

  3. Blueprint Medicines stock price target cut to $77 from $100 at Stifel Nicolaus

    6:43 a.m. Nov. 2, 2022

    - Tomi Kilgore

  4. Blueprint Medicines downgraded to perform from outperform at Oppenheimer

    6:41 a.m. Nov. 2, 2022

    - Tomi Kilgore

  6. Blueprint Medicines started at outperform with $80 stock price target at Oppenheimer

    6:37 a.m. July 8, 2022

    - Tomi Kilgore

  7. Biotech Stocks Finally Rose in June. What Does It Mean?

    8:07 a.m. July 1, 2022

    - Barron's Online

  9. Blueprint Medicines upgraded to buy from hold at Stifel Nicolaus

    11:36 a.m. Jan. 25, 2022

    - Tomi Kilgore

  10. Blueprint Medicines coverage resumed at Stifel with hold stock rating and $105 target price

    6:07 a.m. Sept. 30, 2021

    - Tonya Garcia

  11. Blueprint Medicines started at hold with $110 stock price target at Stifel Nicolaus

    8:00 a.m. Dec. 3, 2020

    - Tomi Kilgore

  12. Here Are Stocks That Benefit Under Different Election Outcomes

    11:26 a.m. Oct. 20, 2020

    - Barron's Online

  14. The Pandemic Speeds Up the Health-Care Revolution

    5:01 p.m. Oct. 6, 2020

    - Barron's Online

  15. Blueprint Medicines shares gain on deal with Roche

    7:28 a.m. July 14, 2020

    - Jaimy Lee

  16. Roche, Blueprint to co-develop lung-cancer drug

    1:18 a.m. July 14, 2020

    - MarketWatch.com

  17. 7 Biotech Stocks to Buy for a Post-Pandemic World

    9:48 p.m. Aug. 17, 2020

    - Barron's Online

  18. Blueprint Medicines upgraded to outperform at BMO Capital

    7:37 a.m. March 17, 2020

    - Tomi Kilgore

  19. Blueprint Medicines upgraded to buy from hold at Deutsche Bank

    6:26 a.m. March 17, 2020

    - Tomi Kilgore

  20. Blueprint Medicines started at market perform at BMO Capital

    9:16 a.m. Jan. 28, 2020

    - Tomi Kilgore

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bpmc

Other News on BPMC

  1. 10-K: BLUEPRINT MEDICINES CORP

    5:27 p.m. Feb. 16, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Top 5 4th Quarter Trades of CADIAN CAPITAL MANAGEMENT, LP

    12:00 a.m. Feb. 15, 2023

    - GuruFocus.com

  10. Amgen (AMGN) to Report Q3 Earnings: What's in the Cards?

    11:48 a.m. Oct. 31, 2022

    - Zacks.com

  11. Top 5 3rd Quarter Trades of SIB LLC

    12:00 p.m. Oct. 27, 2022

    - GuruFocus.com

  12. Pfizer (PFE) to Report Q3 Earnings: What's in the Cards?

    11:06 a.m. Oct. 26, 2022

    - Zacks.com

  16. EMERALD ADVISERS, LLC Buys 1, Sells 4 in 3rd Quarter

    4:00 p.m. Oct. 25, 2022

    - GuruFocus.com

/news/pressrelease/company/us/bpmc

Press Releases on BPMC

  2. Blueprint Medicines Reports First Quarter 2023 Results

    6:00 a.m. May 4, 2023

    - PR Newswire - PRF

  10. Blueprint Medicines Reports Fourth Quarter and Full Year 2022 Results

    7:00 a.m. Feb. 16, 2023

    - PR Newswire - PRF

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.